Wuxi Rex Medical Robot Raises Tens of Millions for Self-Balancing Exoskeleton
On November 16, 2026, Wuxi Rex Medical Robot completed an early strategic financing round totaling tens of millions of yuan. BGI Songhe led the round, while Meian Innovation participated as a co-investor.
The company focuses on brain science and has built a suspension-free, frameless self-balancing exoskeleton. Instead of using overhead harnesses or rigid support frames, the system is designed to guide patients through real movements that follow natural human biomechanics. Rex Medical says the platform targets ultra-early reconstruction of neurological function, a window in which rehabilitation may have greater impact.
The proceeds will fund R&D for both serious medical and consumer medical products, along with a global commercialization layout. The financing reflects rising investor interest in exoskeleton systems that merge robotics, rehabilitation, and neuroscience. By removing suspension and frame constraints, the company hopes to make training more natural and potentially extend exoskeleton-assisted therapy to earlier stages of recovery.